The Food and Drug Administration is unveiling a plan to ease the approval and market entry of “biosimilars,” lower-cost copies of complex multibillion-dollar biotech drugs that have often been blocked by court actions.
Fda Unveils Effort To Get 'biosimilar' Drugs On The Market Faster
WSJ.com: Asia Home, Wall Street Journal: Home Asia
Wed, 07/18/2018 - 11:11am
RELATED ARTICLES
- Stocks Fall as Investors Pause on Trade
Stocks fell, erasing early gains as investors continued to track trade negotiations between the U.S. and China as the two nations appear to inch closer to a pact. More - House Panel Requests Documents From Associates of Trump
Democrats intensified their investigations into President Trump and his associates, with House committees demanding records related to his business dealings, interactions with the Justice Department and communications with Russian President Vladimir Putin. More - U.S. Probes Titanium Imports in Possible Tariff Case
The Commerce Department will look into potential national-security risks in imports of the metal at the request of domestic producer Timet. More - China Accuses Detained Canadians of Espionage
China accused two detained Canadians of working together to steal Chinese state secrets, moving ahead with a politically charged investigation seen as retribution for Canada’s arrest of a senior Huawei executive. More - North Korea Still Using Uranium-Enrichment Facility, U.N. Agency Says
North Korea is still using a uranium-enrichment facility at the heart of last week’s summit between President Trump and North Korean leader Kim Jong Un, the United Nations atomic agency said. More - Purdue Pharma Preparing Possible Bankruptcy Filing
Purdue Pharma is working with advisers on a possible bankruptcy filing as it seeks to contain liability from suits alleging it fueled the U.S. opioid epidemic. More
BING NEWS:
- Medscape Medical News
Alert FDA OKs Ivosidenib for IDH1-mutated Myelodysplastic Syndromes The FDA approval was based on a small study, in which 38.9% of patients with relapsed or refractory disease went into complete ...
04/22/2024 - 12:59 pm | View Link - Sustainable Biosimilar Markets Achieve Widespread Market Uptake Through Collective Action
Despite current challenges in biosimilar market growth due to stakeholder disagreements, a recent commentary proposes that applying collective action theory can achieve widespread biosimilar market ...
04/22/2024 - 1:00 am | View Link - Navigating the Patent Thicket: Balancing Innovation, Biosimilar Access in the Biologics Market
Ha Kung Wong, JD, a patent attorney, explores the challenges of "patent thickets" in the biologics market, where a complex web of patents can hinder development of more affordable biosimilar drugs.
04/21/2024 - 1:00 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more